The contractor shall provide preclinical development support for candidate products and drug development act. The scope of work encompasses activities that range from initial product discovery to…
Active Awarded Last action
- Contract number
- 75N93021D00006
- Awardee
-
Board Of Regents Of The University Of Nebraska UEI G15AG3BLLMH4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $372,062 obligated
Award facts
- Opportunity
-
- Preclinical Services for HIV Therapeutics Pre-Solicitation · 75N93019R00021 · Posted Oct 4, 2019
- Preclinical Services for HIV Therapeutics Solicitation · Posted Dec 5, 2019
- Combined order value
- $1,221,066 Current and potential, with all options
- Last date to order 86% complete
- IDV ceiling <1% used
- $107,274,471.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a multiple-award indefinite-delivery contract to Board Of Regents Of The University Of Nebraska on October 15, 2020, with a ceiling value of $107,274,471 and an ultimate completion date of October 14, 2027. The contract carries no set-aside restriction overall, though the originating solicitation designated Task Area B (synthesis of therapeutic agents) as set-aside for small business concerns under NAICS 541715 with a 1,000-employee size standard.
Place of performance is Omaha, Nebraska. The contract supports preclinical development activities for candidate HIV, hepatitis B, hepatitis C, and mycobacterium products and drug development, encompassing seven task areas: in vitro testing, synthesis of therapeutic agents, small animal models, formulation development and clinical dosage manufacturing, preclinical pharmacology and toxicology, and a reagent program for infectious diseases. Scope extends from initial product discovery through activities required to support clinical trials and product licensure.
The contract runs for seven years. The originating solicitation anticipated 6–21 task orders annually, valued at approximately $500,000 to $5,000,000 each.
Recent delivery-order activity under this IDIQ includes a $1,207,737 order issued August 1, 2024, for pharmacokinetic/pharmacodynamic evaluation and assessment of T-5224's effect on HIV-1 transcriptional activity in an HIV-1-mouse model, with performance in Omaha, Nebraska and completion by November 30, 2026. An April 15, 2021 delivery order for $13,328.86 funded development of a quality assurance/quality control plan and task order initiation meeting support. All delivery orders carry cost-no-fee pricing.
Description
The contractor shall provide preclinical development support for candidate products and drug development act. The scope of work encompasses activities that range from initial product discovery to those required to support trials and/or product licens
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93021D00006?
75N93021D00006 was awarded to Board Of Regents Of The University Of Nebraska by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 15, 2020.
How much is contract 75N93021D00006 worth?
Orders under 75N93021D00006 have obligated $372,062. Their combined current value, with exercised options, is $1,221,066. 75N93021D00006's own ceiling is $107,274,471.
How many orders have been placed under contract 75N93021D00006?
3 orders have been placed under 75N93021D00006, the latest on August 1, 2024.
Who can order from contract 75N93021D00006?
75N93021D00006 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93021D00006 part of a contract vehicle?
Yes. 75N93021D00006 is part of Preclinical Services for HIV Therapeutics.
Was contract 75N93021D00006 competed?
The extent of competition for 75N93021D00006 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV